SKI Market

A+| A| A-|

Indian Indices

Sensex

76,365.88 -1,130.48
( -1.46%)

Global Indices

Nasdaq

48,888.32 -274.62
(-0.56%)

Dow Jones

7,157.73 -2.07
(-0.03%)

Hang Seng

59,839.06 -698.30
(-1.15%)

Nikkei 225

10,208.73 -124.06
(-1.20%)

Forex

USD-INR

94.52 0.35
(0.37%)

EUR-INR

110.65 0.18
(0.17%)

GBP-INR

127.71 0.18
(0.14%)

JPY-INR

0.59 0.00
(0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

97.8

426829.69

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.9

Back

Grindwell Norton consolidated net profit rises 11.12% in the September 2025 quarter

Oct 30,2025

Net profit of Grindwell Norton rose 11.12% to Rs 106.88 crore in the quarter ended September 2025 as against Rs 96.18 crore during the previous quarter ended September 2024. Sales rose 11.73% to Rs 771.70 crore in the quarter ended September 2025 as against Rs 690.71 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	771.70	690.71	12
OPM %	18.23	18.71	-
PBDT	169.58	150.33	13
PBT	143.25	127.51	12
NP	106.88	96.18	11

76,365.88 -1,130.48 ( -1.46%)

48,888.32 -274.62 (-0.56%)

7,157.73 -2.07 (-0.03%)

59,839.06 -698.30 (-1.15%)

10,208.73 -124.06 (-1.20%)

94.52 0.35 (0.37%)

110.65 0.18 (0.17%)

127.71 0.18 (0.14%)

0.59 0.00 (0.25%)